HHS Cuts Gut Agency for Healthcare Research and Quality: 100+ Grants Worth $250 Million Canceled

The Agency for Healthcare Research and Quality, a small federal office that studies patient safety, hospital errors, and how to make American healthcare work better, has been gutted under Health Secretary Robert F. Kennedy Jr.

AHRQ has lost an estimated 75% of its staff since the start of the second Trump administration, largely through DOGE-driven firings and retirements, according to Ars Technica. In July, the agency sent form-letter cancellations to roughly 150 researchers. More than 100 grants worth over $250 million have been terminated, according to a tracking tool built by the nonprofit AcademyHealth and cited by both Ars Technica and MedPage Today.

The dollar figures matter because Congress already approved the spending. Lawmakers appropriated $345 million for AHRQ in fiscal year 2026. As of the most recent reporting cited by MedPage Today, the agency had spent less than $15 million on grants and had not issued a single new one.

Health policy researchers Aaron Carroll and David Atkins, writing in the Annals of Internal Medicine and cited by Ars Technica, said AHRQ's survival under the current administration is now an "open question." Carroll, who also leads AcademyHealth, told MedPage Today the cancellations amount to "a quarter of a billion dollars worth of grants, which are all focused on things Americans care about."

What actually got canceled

The scale here isn't abstract. According to Ars Technica and MedPage Today, terminated projects include research on training rural healthcare workers in Connecticut to handle maternal medical emergencies, expanding home dialysis access in New York, reducing patient falls in rural Colorado hospitals, cutting unnecessary antibiotic use in Utah, improving autism screening for Black children in North Carolina, and managing chronic pain to reduce opioid reliance in Virginia.

Nearly 200 research programs across almost 30 states have been disrupted, according to a letter sent to Kennedy by Senators Richard Blumenthal of Connecticut and Tammy Baldwin of Wisconsin, joined by 28 other Democratic senators. The letter called the cancellations "sabotage" and demanded HHS "immediately rescind" them.

The senators also flagged something specific and testable: the termination letters researchers received reportedly contained contradictory explanations and cited incorrect information, according to MedPage Today, which reviewed letters shared with it directly. HHS has not publicly responded to that specific claim about the letters' accuracy.

HHS's stated rationale, and its limits

The termination notices reviewed by MedPage Today say AHRQ is "adjusting its discretionary health services research award portfolio in order to better prioritize agency resources." That's the extent of the public justification on record. HHS has not laid out, in public statements captured by these sources, which specific priorities are replacing the canceled grants or why researchers went months without status updates before getting cut off.

If the administration believes AHRQ's prior grant portfolio was misdirected or duplicative of other research, that's a defensible position for an administration to hold, and voters gave Trump a mandate to reshape federal agencies he views as bloated or ideologically captured. But a generic form letter citing "prioritization," with no accompanying data on what's being prioritized instead, doesn't give Congress or the public much to evaluate that claim against. Congress appropriated specific dollar amounts for specific purposes. If HHS wants to redirect that money, the normal path is to ask Congress to reprogram it, not simply decline to spend it.

The politics around Kennedy

Kennedy's handling of AHRQ is unfolding alongside a broader pattern of controversy. A newsletter from Protect Our Care, a Democratic-aligned advocacy group, tied the AHRQ story to Kennedy's separate push on vaccine policy, including a Trump executive order on the MMR vaccine schedule that drew criticism from the conservative Wall Street Journal editorial board, among others. That's a different fight with its own facts, but it's shaping how Kennedy's health policy moves are being read on Capitol Hill.

Not every part of Kennedy's agenda has drawn uniform opposition. As Breitbart's reporting on his confirmation process noted, some Democrats, including former Ohio Congressman Tim Ryan and Senator Cory Booker, have expressed interest in working with Kennedy on food policy and ultraprocessed food reform, even while opposing his vaccine views. Kennedy is not uniformly opposed by the left, and the AHRQ fight is specifically about grant funding and appropriations law, not about MAHA's food agenda.

What happens next

The 30 senators' letter demands Kennedy rescind the cancellations immediately. HHS has not issued a public reply accepting or rejecting that demand as of this writing. AcademyHealth's tracker shows the $250 million figure climbing, and Carroll has said he expects it to rise further.

The unresolved legal question is whether HHS's slow-walking of congressionally appropriated funds violates the Impoundment Control Act, which restricts a president's ability to withhold money Congress has directed be spent. No lawsuit or GAO ruling on AHRQ funding specifically has been reported in these accounts. Whether Congress moves beyond letters to actual oversight hearings or funding riders will determine whether AHRQ's remaining research survives fiscal year 2026 intact.